In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer

S. C. Modesitt, P. Ramirez, Z. Zu, D. Bodurka-Bevers, D. Gershenson, J. K. Wolf

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences